Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial
The objective of this study is to compare the effects of vildagliptin and gliclazid...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Andre Gustavo Daher Vianna, Claudio Silva de Lacerda, Luciana Muniz Pechmann, Michelle Garcia Polesel, Emerson Cestari Marino, Victoria Zeghbi Cochenski Borba and Fellype de Carvalho Barreto Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Men | Menopause | Metabolic Syndrome | Study | Women